DIVY

MELBOURNE: Mesoblast’s chief financial officer Josh Munter will leave the business by the ... read more

MELBOURNE: Clinical biotech firm Opthea will expand its phase 3 trial for a ... read more

MELBOURNE: Billion-dollar pharmaceuticals developer Clinuvel has reported good news from the very early ... read more

WAGGA WAGGA: Airlines are again facing a period of significant turmoil due to ... read more